Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Multicentre, Multinational, Open-Label Trial (including Double-Blind, Placebo-Controlled Cross-Over Extension Part) to Evaluate the Time to Significant Pain Relief with Fentanyl TAIFUN in the Treatment of Breakthrough Pain in Patients with Cancer on Maintenance Opioid Therapy for Persistent Pain.

Next Previous
X
Search
Trial Profile

A Multicentre, Multinational, Open-Label Trial (including Double-Blind, Placebo-Controlled Cross-Over Extension Part) to Evaluate the Time to Significant Pain Relief with Fentanyl TAIFUN in the Treatment of Breakthrough Pain in Patients with Cancer on Maintenance Opioid Therapy for Persistent Pain.

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 13 Jul 2011

Price :

$35 *

Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Fentanyl (Primary) ; Fentanyl
  • Indications Cancer pain
  • Focus Therapeutic Use
  • Acronyms FIND-2

    • Most Recent Events

    • 31 Jan 2007 The first patient has been enrolled in the second part of the trial, according to LAB International media release.
    • 15 Jun 2006 New trial record.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top